Yong-Xi Chen1,2, Jing Xu1,2, Xiao-Xia Pan1,2, Ping-Yan Shen1,2, Xiao Li1,2, Hong Ren1,2, Xiao-Nong Chen1,2, Li-Yan Ni1,2, Wen Zhang3,4, Nan Chen1,2. 1. From the Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China. 2. Y.X. Chen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; J. Xu, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; X.X. Pan, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; P.Y. Shen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; X. Li, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; H. Ren, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; X.N. Chen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; L.Y. Ni, BSc, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; W. Zhang, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; N. Chen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine. 3. From the Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China. zhangwen255@163.com chen-nan@medmail.com.cn. 4. Y.X. Chen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; J. Xu, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; X.X. Pan, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; P.Y. Shen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; X. Li, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; H. Ren, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; X.N. Chen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; L.Y. Ni, BSc, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; W. Zhang, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine; N. Chen, MD, Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine. zhangwen255@163.com chen-nan@medmail.com.cn.
Abstract
OBJECTIVE: Renal vasculitis is one of the most common manifestations of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) and renal histology is a key predictor of the outcome. A new histopathologic classification was proposed and validated, but the results are still debated. METHODS: We performed a retrospective analysis to validate the histopathologic classification and performed a metaanalysis to evaluate its predictive value. There were 186 patients with ANCA-associated renal vasculitis diagnosed at Ruijin Hospital who were enrolled in the retrospective study. The metaanalysis considered the data for 1601 patients. RESULTS: In our retrospective study, patients with focal class had the best renal outcome while patients with mixed class had the worst (p < 0.001). Metaanalysis showed that patients with focal class had better renal outcome than did those with crescentic class [risk ratio (RR) 0.23, 95% CI 0.16-0.34, p < 0.00001], with no evidence of heterogeneity (I2 = 0%, p = 0.96). Patients with crescentic class had better renal outcome than did those with sclerotic class (RR 0.52, 95% CI 0.41-0.64, p < 0.00001), with no evidence of heterogeneity (I2 = 2%, p = 0.43). We did not find statistical significance regarding renal outcome between mixed and crescentic classes (RR 1.14, 95% CI 0.91-1.43, p = 0.27), with no evidence of heterogeneity (I2 = 23%, p = 0.19). The retrospective study showed that lung and upper respiratory tract involvement were the most common extrarenal manifestations. CONCLUSION: We demonstrated the clinical utility of histopathologic classification in determining renal outcome in patients with AAV. Metaanalysis showed that patients with focal class had the best outcome while sclerotic class had the worst.
OBJECTIVE:Renal vasculitis is one of the most common manifestations of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) and renal histology is a key predictor of the outcome. A new histopathologic classification was proposed and validated, but the results are still debated. METHODS: We performed a retrospective analysis to validate the histopathologic classification and performed a metaanalysis to evaluate its predictive value. There were 186 patients with ANCA-associated renal vasculitis diagnosed at Ruijin Hospital who were enrolled in the retrospective study. The metaanalysis considered the data for 1601 patients. RESULTS: In our retrospective study, patients with focal class had the best renal outcome while patients with mixed class had the worst (p < 0.001). Metaanalysis showed that patients with focal class had better renal outcome than did those with crescentic class [risk ratio (RR) 0.23, 95% CI 0.16-0.34, p < 0.00001], with no evidence of heterogeneity (I2 = 0%, p = 0.96). Patients with crescentic class had better renal outcome than did those with sclerotic class (RR 0.52, 95% CI 0.41-0.64, p < 0.00001), with no evidence of heterogeneity (I2 = 2%, p = 0.43). We did not find statistical significance regarding renal outcome between mixed and crescentic classes (RR 1.14, 95% CI 0.91-1.43, p = 0.27), with no evidence of heterogeneity (I2 = 23%, p = 0.19). The retrospective study showed that lung and upper respiratory tract involvement were the most common extrarenal manifestations. CONCLUSION: We demonstrated the clinical utility of histopathologic classification in determining renal outcome in patients with AAV. Metaanalysis showed that patients with focal class had the best outcome while sclerotic class had the worst.
Authors: L García; C E Pena; R Águila Maldonado; C Costi; M Mamberti; E Martins; M A García Journal: Clin Rheumatol Date: 2019-06-20 Impact factor: 2.980
Authors: H Marco; J Draibe; J Villacorta; L F Quintana; N Martin; R Garcia-Osuna; C Cabre; M A Martín-Gómez; A Balius; A Saurina; M Picazo; I Gich-Saladich; M Navarro-Díaz; M Praga; T Cavero; J Ballarin; M M Díaz-Encarnación Journal: Clin Rheumatol Date: 2018-03-09 Impact factor: 2.980
Authors: Alvise Berti; Emilie Cornec-Le Gall; Divi Cornec; Marta Casal Moura; Eric L Matteson; Cynthia S Crowson; Aishwarya Ravindran; Sanjeev Sethi; Fernando C Fervenza; Ulrich Specks Journal: Nephrol Dial Transplant Date: 2019-09-01 Impact factor: 5.992
Authors: Emma E van Daalen; Maria A C Wester Trejo; Arda Göçeroğlu; Franco Ferrario; Kensuke Joh; Laure-Hélène Noël; Yayoi Ogawa; Suzanne Wilhelmus; Miriam J Ball; Eva Honsova; Zdenka Hruskova; Renate Kain; Tomoyoshi Kimura; Marek Kollar; Andreas Kronbichler; Kristine Lindhard; Xavier Puéchal; Steven Salvatore; Wladimir Szpirt; Hideki Takizawa; Vladimir Tesar; Annelies E Berden; Olaf M Dekkers; E Christiaan Hagen; Jan Oosting; Chinar Rahmattulla; Ron Wolterbeek; Willem Jan Bos; Jan A Bruijn; Ingeborg M Bajema Journal: Clin J Am Soc Nephrol Date: 2020-07-28 Impact factor: 8.237